BIOCON:NSE
Biocon Ltd
358,65Â INR
arrow_downward
−0,99%(−3,60) 1 d
30 apr., 15:30:01 GMT+5:30 · INR
search
Alla symboler
1 d
5 d
1 m
6 m
Hittills i år
1 år
5 år
MAX
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för BIOCON …
Öppen
360,50Â INR
Högt
361,65Â INR
LÃ¥gt
354,25Â INR
Börsvärde
580,84Â md
Genomsn. vol.
3,39Â mn
Volym
2,00Â mn
Utdelning
0,14Â %
Kvartalsvis utdelning
0,13Â INR
Ex-utdelningsdatum
4 juli 2025
P/E-tal
73,95
52v högst
424,95Â INR
52v lägst
317,00Â INR
EPS
4,85Â INR
Utestående aktier
600,00Â mn
Antal anställda
16Â tn
Nyheter och artiklar
Från källor på webben
CNBC
·
för 1 dag sedan
Can AI outperform doctors? Experts weigh the pros and cons
Profil
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. The company was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Om Biocon Ltd
VdSiddharth Mittal
Anställda16,4 tn
Grundades29 nov. 1978
HuvudkontorBangalore, Karnataka, Indien
Sektor-
Webbplatsbiocon.com
AI-innehåll kan innehålla fel. Läs mer